Concepts (50)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PPAR alpha | 4 | 2023 | 29 | 3.090 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2023 | 52 | 1.730 |
Why?
|
| cis-trans-Isomerases | 2 | 2023 | 32 | 1.710 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2021 | 18 | 1.630 |
Why?
|
| Macular Degeneration | 2 | 2021 | 21 | 1.620 |
Why?
|
| Receptors, LDL | 2 | 2021 | 64 | 1.590 |
Why?
|
| Diabetic Retinopathy | 2 | 2022 | 64 | 1.300 |
Why?
|
| Mice | 9 | 2023 | 2372 | 1.200 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 981 | 1.120 |
Why?
|
| Retina | 4 | 2023 | 50 | 1.090 |
Why?
|
| Mice, Knockout | 6 | 2023 | 425 | 1.080 |
Why?
|
| Eye Proteins | 2 | 2023 | 33 | 1.060 |
Why?
|
| Retinal Degeneration | 1 | 2023 | 14 | 0.890 |
Why?
|
| Retinal Diseases | 1 | 2022 | 18 | 0.880 |
Why?
|
| Genes, Dominant | 1 | 2022 | 26 | 0.850 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 3 | 0.840 |
Why?
|
| Fibrosis | 1 | 2021 | 103 | 0.810 |
Why?
|
| Animals | 9 | 2023 | 7302 | 0.800 |
Why?
|
| Diabetes Complications | 1 | 2022 | 171 | 0.770 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 370 | 0.660 |
Why?
|
| Capillary Permeability | 1 | 2013 | 15 | 0.470 |
Why?
|
| Down-Regulation | 1 | 2013 | 143 | 0.450 |
Why?
|
| Cornea | 2 | 2023 | 15 | 0.440 |
Why?
|
| Wound Healing | 2 | 2023 | 182 | 0.400 |
Why?
|
| Mutation | 2 | 2023 | 466 | 0.360 |
Why?
|
| Cells, Cultured | 2 | 2021 | 800 | 0.280 |
Why?
|
| Electroretinography | 1 | 2023 | 4 | 0.230 |
Why?
|
| Epithelium | 1 | 2023 | 21 | 0.230 |
Why?
|
| Nucleotidyltransferases | 1 | 2022 | 7 | 0.220 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 28 | 0.220 |
Why?
|
| Microglia | 1 | 2022 | 48 | 0.220 |
Why?
|
| Serpins | 1 | 2022 | 6 | 0.210 |
Why?
|
| Neovascularization, Pathologic | 1 | 2022 | 81 | 0.210 |
Why?
|
| Ischemia | 1 | 2022 | 92 | 0.210 |
Why?
|
| Smad Proteins | 1 | 2021 | 7 | 0.210 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2021 | 7 | 0.210 |
Why?
|
| Vision, Ocular | 1 | 2022 | 30 | 0.210 |
Why?
|
| beta Catenin | 1 | 2022 | 37 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 66 | 0.200 |
Why?
|
| Mitochondria | 1 | 2023 | 174 | 0.200 |
Why?
|
| Membrane Proteins | 1 | 2022 | 256 | 0.200 |
Why?
|
| Humans | 4 | 2023 | 29220 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 711 | 0.170 |
Why?
|
| Inflammation | 1 | 2022 | 508 | 0.170 |
Why?
|
| Trypsin | 1 | 2013 | 12 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 248 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2013 | 281 | 0.110 |
Why?
|
| Glucose | 1 | 2013 | 164 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 519 | 0.100 |
Why?
|
| Rats | 1 | 2013 | 1604 | 0.090 |
Why?
|